Back

Unveiling the eligibility for screening of cardiac amyloidosis in a real world population

13 May 2024 (16:00 - 16:45)
Organised by: Logo
Congress Presentation Part of: Valvular heart disease 4 Epidemiology, Prognosis, Outcome HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Filipa Gerardo

Hospital Professor Doutor Fernando Fonseca, Amadora (Portugal)

6 More presentations in this session

Presentation thumbnail
The main predictors of in-hospital mortality in patients with infective endocarditis: a retrospective single-center study.
Doctor N. Ilchyshyn (Almada, PT)
Abstract Slides Video
Presentation thumbnail
Transcatheter aortic valve replacement for low-flow, low-gradient aortic stenosis: unravelling the impact of contractile reserve on survival
Doctor T. Pereira dos Santos (Coimbra, PT)
Abstract Slides Video
Presentation thumbnail
Coronary artery calcium score and prognosis in patients undergoing transcatheter aortic valve replacement
Doctor V. Lopes (Coimbra, PT)
Abstract Slides Video
Presentation thumbnail
Long-term echocardiographic outcomes: the role of valve-sparing and valve-replacing approaches
Miss V. Zieniute (Kaunas, LT)
Abstract Slides Video
Presentation thumbnail
Aortic valve calcification as a surrogate parameter for paravalvular regurgitation following transcatheter aortic valve implantation
Doctor F. Duarte (Ponta Delgada, PT) Doctor R. Teixeira (Vila Nova de Gaia, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Valvular heart disease 4

The Event

Event poster

Heart Failure 2024

13 May 2024 16:00 CET
You may be interested in
thumbnail
Congress Presentation
Epidemiology of amyloidosis in heart failure and red flags
thumbnail
Congress Presentation
Approach to family screening in hereditary transthyretin cardiac amyloidosis
thumbnail
Congress Session
Transthyretin cardiac amyloidosis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources